• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组蛋白去乙酰化酶抑制剂与去甲基化剂协同诱导骨髓瘤细胞系U266凋亡及p16基因重新表达

[Apoptosis and re-expression of p16 gene in the myeloma cell line U266 induced by synergy of histone deacetylase inhibitor and demethylating agent].

作者信息

Du Hong-ling, Qi Yu, Shi Yong-jin, Bu Ding-fang, Wu Shu-lan

机构信息

Department of Hematology, 2. Central Lab, First Hospital, Peking University, Beijing 100034, P. R. China.

出版信息

Ai Zheng. 2002 Oct;21(10):1057-61.

PMID:12508642
Abstract

BACKGROUND & OBJECTIVE: Histone deacetylation is associated with transcriptional activation controlled by DNA methylation. It is important to investigate changes of tumor cells treated with agent through two kinds of mechanisms. This study was designed to investigate the synergic effect of histone deacetylase inhibitor, sodium phenylbutyrate(SPB), and demethylating agent, 5-Aza-2'-deoxycytidine(5-Aza-CdR), on cell growth and explore the possibility of re-expression of the hypermethylated and silenced p16 gene in the myeloma cell line U266.

METHODS

The cell cycle was analyzed by flow cytometry. Apoptosis was observed by transmission electron microscopy, DNA ladder, fluorescence-activated cell sorter (FACS). The expression level of p16 was detected by RT-PCR and Western blot analysis.

RESULTS

The apoptotic rates of U266 cells induced by 5-Aza-CdR(1 mumol/L), SPB(1 mmol/L) alone and combination of 5-Aza-CdR and SPB were 15.09%, 89.19%, and 85.18%, respectively. The G1 phase was arrested and sub-G1 phase(50%) was induced by combination of 5-Aza-CdR and SPB. There was no G1 phase arrested when SPB or 5-Aza-CdR was used alone. The proportion of cells in G2 phase was increased with SPB alone. SPB was not able to induce the expression of p16. The expression level of p16 was induced with 5-Aza-CdR. The expression level of both mRNA and protein of p16 was increased significantly by synergy of SPB and 5-Aza-CdR.

CONCLUSIONS

p16 gene in U266 cell line could be reactivated markedly with synergy of 5-Aza-CdR and SPB with cell cycle arresting in G1 phase. Meanwhile, the cell cycle phase occurring apoptosis that induced by combination of 5-Aza-CdR with SPB is different from that induced by each alone.

摘要

背景与目的

组蛋白去乙酰化与受DNA甲基化控制的转录激活相关。研究通过两种机制处理的肿瘤细胞的变化具有重要意义。本研究旨在探讨组蛋白脱乙酰酶抑制剂苯丁酸钠(SPB)与去甲基化剂5-氮杂-2'-脱氧胞苷(5-氮杂-CdR)对细胞生长的协同作用,并探索骨髓瘤细胞系U266中高甲基化且沉默的p16基因重新表达的可能性。

方法

采用流式细胞术分析细胞周期。通过透射电子显微镜、DNA梯状条带、荧光激活细胞分选仪(FACS)观察细胞凋亡情况。采用逆转录-聚合酶链反应(RT-PCR)和蛋白质免疫印迹分析检测p16的表达水平。

结果

单独使用5-氮杂-CdR(1 μmol/L)、SPB(1 mmol/L)以及5-氮杂-CdR与SPB联合处理U266细胞后的凋亡率分别为15.09%、89.19%和85.18%。5-氮杂-CdR与SPB联合处理使细胞G1期阻滞并诱导亚G1期(50%)出现,单独使用SPB或5-氮杂-CdR时未出现G1期阻滞。单独使用SPB使G2期细胞比例增加。SPB不能诱导p16表达,5-氮杂-CdR可诱导p16表达,SPB与5-氮杂-CdR协同作用显著增加p16的mRNA和蛋白表达水平。

结论

5-氮杂-CdR与SPB协同作用可显著重新激活U266细胞系中的p16基因,并使细胞周期阻滞于G1期。同时,5-氮杂-CdR与SPB联合诱导凋亡的细胞周期时相与各自单独诱导的不同。

相似文献

1
[Apoptosis and re-expression of p16 gene in the myeloma cell line U266 induced by synergy of histone deacetylase inhibitor and demethylating agent].组蛋白去乙酰化酶抑制剂与去甲基化剂协同诱导骨髓瘤细胞系U266凋亡及p16基因重新表达
Ai Zheng. 2002 Oct;21(10):1057-61.
2
Re-expression of p16 gene in the myeloma cell line U266 induced by synergy of sodium butyrate and 5-Aza-2'-deoxycytidine.丁酸钠与5-氮杂-2'-脱氧胞苷协同诱导骨髓瘤细胞系U266中p16基因的重新表达。
Di Yi Jun Yi Da Xue Xue Bao. 2002 Nov;22(11):981-4.
3
Inhibition of DNA methylation by 5-aza-2'-deoxycytidine suppresses the growth of human tumor cell lines.5-氮杂-2'-脱氧胞苷对DNA甲基化的抑制作用可抑制人肿瘤细胞系的生长。
Cancer Res. 1998 Jan 1;58(1):95-101.
4
Increased expression of unmethylated CDKN2D by 5-aza-2'-deoxycytidine in human lung cancer cells.5-氮杂-2'-脱氧胞苷增加人肺癌细胞中未甲基化CDKN2D的表达。
Oncogene. 2001 Nov 22;20(53):7787-96. doi: 10.1038/sj.onc.1204970.
5
Promoter histone H3 lysine 9 di-methylation is associated with DNA methylation and aberrant expression of p16 in gastric cancer cells.启动子组蛋白H3赖氨酸9二甲基化与胃癌细胞中的DNA甲基化及p16异常表达相关。
Oncol Rep. 2009 Nov;22(5):1221-7. doi: 10.3892/or_00000558.
6
[Synergistic effect of DNA methylation inhibitor and histone deacetylase inhibitor on RASSF1A gene expression in U266 cells.].DNA甲基化抑制剂与组蛋白去乙酰化酶抑制剂对U266细胞中RASSF1A基因表达的协同作用。
Zhonghua Xue Ye Xue Za Zhi. 2010 Apr;31(4):223-7.
7
Inhibition of histone deacetylation does not block resilencing of p16 after 5-aza-2'-deoxycytidine treatment.组蛋白去乙酰化的抑制作用并不能阻止5-氮杂-2'-脱氧胞苷处理后p16基因的重新沉默。
Cancer Res. 2007 Jan 1;67(1):346-53. doi: 10.1158/0008-5472.CAN-06-2845.
8
[Effects of 5-Aza-2-deoxycytidine on DNA methylation of anti-oncogenes in non-small cell lung cancer cells].[5-氮杂-2'-脱氧胞苷对非小细胞肺癌细胞中抑癌基因DNA甲基化的影响]
Zhonghua Zhong Liu Za Zhi. 2012 Sep;34(9):658-63. doi: 10.3760/cma.j.issn.0253-3766.2012.09.004.
9
Effect of 5-aza-2'-deoxycytidine on cell proliferation of non- small cell lung cancer cell line A549 cells and expression of the TFPI-2 gene.5-氮杂-2'-脱氧胞苷对非小细胞肺癌细胞系A549细胞增殖及TFPI-2基因表达的影响。
Asian Pac J Cancer Prev. 2013;14(7):4421-6. doi: 10.7314/apjcp.2013.14.7.4421.
10
Demethylating agent 5-aza-2-deoxycytidine enhances susceptibility of breast cancer cells to anticancer agents.去甲基化药物 5-氮杂-2'-脱氧胞苷增强乳腺癌细胞对抗癌药物的敏感性。
Mol Cell Biochem. 2010 Sep;342(1-2):101-9. doi: 10.1007/s11010-010-0473-y. Epub 2010 May 9.

引用本文的文献

1
Clinicopathological significance of the hypermethylation in multiple myeloma, a systematic review and meta-analysis.多发性骨髓瘤中高甲基化的临床病理意义:一项系统评价和荟萃分析
Oncotarget. 2017 Jun 27;8(47):83270-83279. doi: 10.18632/oncotarget.18742. eCollection 2017 Oct 10.